Adam Shlien
Impact in
- Genetics top 1%
- Genomic variations and chromosomal abnormalities
- Genetic Associations and Epidemiology
- Genetic Mapping and Diversity in Plants and Animals
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 16
- Aging 1
- Co-authors
- David MalkinGísli MássonKāri StefánssonSigurjón A. GuðjónssonG.M. JonsdottirThorgeir E. ThorgeirssonDaníel F. GuðbjartssonMichael L. Frigge
- Journals
- Cancer Research (5 papers)Neuro-Oncology (4 papers)Journal of Clinical Oncology (3 papers)Blood (2 papers)Nature Communications (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Adam Shlien
57 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Genetics 1.4k
- Cancer Research 639
- Molecular Biology 1.9k
- Genetics 217
- Oncology 460
Countries citing papers authored by Adam Shlien
This map shows the geographic impact of Adam Shlien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Shlien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Shlien more than expected).
Fields of papers citing papers by Adam Shlien
This network shows the impact of papers produced by Adam Shlien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Shlien. The network helps show where Adam Shlien may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam Shlien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 0 | |
| 14 | 2020 | 3 | |
| 15 | 2018 | 43 | |
| 16 | 2014 | 21 | |
| 17 | 2011 | 52 | |
| 18 | 2010 | 126 | |
| 19 | 2010 | 25 | |
| 20 | 2009 | 255 |
About Adam Shlien
Adam Shlien is a scholar working on Cancer Research, Aging, Oncology, Genetics and Molecular Biology, having authored 62 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (16 papers), Sarcoma Diagnosis and Treatment (9 papers), RNA modifications and cancer (8 papers), Neuroblastoma Research and Treatments (7 papers), Genomics and Rare Diseases (5 papers), Cancer-related Molecular Pathways (5 papers), RNA and protein synthesis mechanisms (5 papers) and Genomics and Chromatin Dynamics (5 papers). The work is most often cited by research in Genetics (1.4k citations), Cancer Research (639 citations), Molecular Biology (1.9k citations), Genetics (217 citations) and Oncology (460 citations). Adam Shlien has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include David Malkin, Gísli Másson, Kāri Stefánsson, Sigurjón A. Guðjónsson, G.M. Jonsdottir, Thorgeir E. Thorgeirsson, Daníel F. Guðbjartsson, Michael L. Frigge, John Barnard and Jeffrey R. Gulcher. Their work appears in journals such as Cancer Research, Neuro-Oncology, Journal of Clinical Oncology, Blood and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.